https://clinicaltrials.gov/ct2/show/NCT02913482?type=Intr&cond=spinal+muscular+atrophy&phase=0124&lupd_s=07%2F08%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy
DESCRIPTION:
Condition: Muscular Atrophy, Spinal
Intervention: Drug: Risdiplam
Sponsor: Hoffmann-La Roche
Active, not recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT02913482
FIRST POSTED:
Fri, 23 Sep 2016 12:00:00 EDT
LAST UPDATE POSTED:
07/22/20 08:23AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02913482?type=Intr&cond=spinal+muscular+atrophy&phase=0124&lupd_s=07%2F08%2F2020&lupd_d=14&sort=nwst